Average Co-Inventor Count = 7.04
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (15 from 1,535 patents)
2. University of Michigan (1 from 3,370 patents)
3. Facio Intellectual Property B.v. (1 from 1 patent)
4. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
17 patents:
1. 10973820 - Compounds for treatment of diseases related to DUX4 expression
2. 9868736 - Deubiquitinase inhibitors and methods for use of the same
3. 9315454 - Compounds which modulate the CB2 receptor
4. 8957063 - Amine and ether compounds which modulate the CB2 receptor
5. 8846936 - Sulfonyl compounds which modulate the CB2 receptor
6. 8829034 - Compounds which modulate the CB2 receptor
7. 8735430 - Compounds which selectively modulate the CB2 receptor
8. 8383651 - Compounds which selectively modulate the CB2 receptor
9. 8372874 - Compounds which selectively modulate the CB2 receptor
10. 8362039 - Therapeutic uses of compounds which selectively modulate the CB2 receptor
11. 8349871 - Therapeutic uses of compounds which selectively modulate the CB2 receptor
12. 8329735 - Tetrazole compounds which selectively modulate the CB2 receptor
13. 8299111 - Compounds which modulate the CB2 receptor
14. 8048899 - Compounds which selectively modulate the CB2 receptor
15. 7935715 - Compounds which modulate the CB2 receptor